Awarded contract

NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)

Details

Buyer: NHS England
Supplier(s): 6 suppliers
Baxter Healthcare Ltd
ITH Pharma
Lloyds Clinical Limited
Qualasept Ltd (trading as Bath ASU)
QUANTUM PHARMACEUTICAL LIMITED
Sciensus Pharma Services Limited (Healthcare at Home)
Value: GBP 608,000,000
Duration: 4 years
Topic: Pharmaceutical products
Published: 3 April 2024
Source: uk:contracts_finder

Tender description

NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5) Tender Reference: CM/PHR/22/5686/01 Period of framework agreement: 1 April 2024 to 31 March 2028 (covering regions East of England, London, North of England and South East).

Timeline

Completed: Award date1 April 2024
Completed: Award published3 April 2024
Current notice
Next: Contract expiry date31 March 2028in 2 years

About the buyer

NHS England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

33600000 · Pharmaceutical products

Decision makers

Connect with the people behind this procurement.

Job title	Phone number	Work email
Head of Procurement	+44 •••• ••••••	••••••••@nhs-england.gov
Commercial Director	+44 •••• ••••••	••••••••@nhs-england.gov
Procurement Manager	+44 •••• ••••••	••••••••@nhs-england.gov
Category Lead	+44 •••• ••••••	••••••••@nhs-england.gov
Senior Buyer	+44 •••• ••••••	••••••••@nhs-england.gov
Contracts Manager	+44 •••• ••••••	••••••••@nhs-england.gov

6 similar open tenders

See more open tenders related to NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5).

Explore all open tenders